Predictive Oncology Inc. — Director's Dealing 2017

Apr 6, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Skyline Medical Inc. (SKLN)
CIK: 0001446159
Period of Report: 2017-03-31

Reporting Person: ENGLE J MELVILLE (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-31	Stock Options (right to buy)	$2.10	A	2381	Acquired	2027-03-31	Common Stock (2381)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct